12 results · 7ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Titanium MPJ (Toe Implant)TOE JOINT TITANIUM NPC LG, Part ID 16816

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM PC LG, Part ID 17038

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM PC MS, Part ID 17197

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM NPC ML, Part ID 16815

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM PC MD, Part ID 17036

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM NPC SM, Part ID 16813

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM NPC MS, Part ID 17198

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM NPC MD, Part ID 16814

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant) TOE JOINT TITANIUM PC M/L, Part ID 17037

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Titanium MPJ (Toe Implant)TOE JOINT TITANIUM PC SM, Part ID 17035

FDA Enforcement
Class II ·Terminated·BioPro, Inc.·March 9, 2022

Opiate 300 Ng Reagent (OP 1 X 250) for use in conjunction with UniCel DxC 600/800 System(s) and SYNCHRON Systems OP 300 Urine Calibrators, Catalogue No.475024. The OP assay provides a rapid screening procedure for determining the presence of OP and its metabolites in urine.

FDA Enforcement
Class II ·Terminated·Beckman Coulter Inc.·April 29, 2020

Invacare Power Wheelchair, one per box To provide mobility to a person restricted to a sitting position.

FDA Enforcement
Class II ·Terminated·Invacare Corporation·October 2, 2013